AD/PD™️ 2024 – Highlights research on earlier treatment with anti-amyloid immunotherapies

AD/PD™️ 2024 – Highlights research on earlier treatment with anti-amyloid immunotherapies

ADPD 2024™: Earlier treatment with anti-amyloid immunotherapies - Podcast to Practice S1E2Подробнее

ADPD 2024™: Earlier treatment with anti-amyloid immunotherapies - Podcast to Practice S1E2

AD/PD™ 2024 Day 1 HighlightsПодробнее

AD/PD™ 2024 Day 1 Highlights

Next steps in anti-amyloid immunotherapyПодробнее

Next steps in anti-amyloid immunotherapy

Tau-targeted therapy landscape in Alzheimer’s diseaseПодробнее

Tau-targeted therapy landscape in Alzheimer’s disease

AD/PD™ 2024 Faculty - Mark RoithmayrПодробнее

AD/PD™ 2024 Faculty - Mark Roithmayr

AD/PD™ 2024 Speakers - Prof. Robert VassarПодробнее

AD/PD™ 2024 Speakers - Prof. Robert Vassar

AD/PD™ 2024 Day 2 HighlightsПодробнее

AD/PD™ 2024 Day 2 Highlights

Bringing the Microscope to the Clinic: Improving Diagnosis and Treatment of PSP & Related ConditionsПодробнее

Bringing the Microscope to the Clinic: Improving Diagnosis and Treatment of PSP & Related Conditions

AD/PD™ 2024 - Day 2 HighlightsПодробнее

AD/PD™ 2024 - Day 2 Highlights

AD/PD™ 2024 - Day 3 HighlightsПодробнее

AD/PD™ 2024 - Day 3 Highlights

NextGen 2024: Weaning MedicationsПодробнее

NextGen 2024: Weaning Medications

GRAPPA Virtual Congress Highlights AAD 2024Подробнее

GRAPPA Virtual Congress Highlights AAD 2024

AD/PD™ 2025 Vienna - 40 Years of Advances in Science and TherapyПодробнее

AD/PD™ 2025 Vienna - 40 Years of Advances in Science and Therapy

Masterclass 2024 | Side effects and management of myeloma and AL amyloidosis treatmentsПодробнее

Masterclass 2024 | Side effects and management of myeloma and AL amyloidosis treatments